Cardiovascular

• 
• 
• 
• 

Recent FDA approvals have spurred the demand for viral vector products,prompting the need for more efficient bioproduction methods. In this context,Vanderbilt researchers have engineered a new cell line with significantlyenhanced viral production capabilities compared to traditional cell lines. Thisinnovation is expected to lead to substantial cost savings in viral vectorproduction and improved viral products, two key advantages in the industry.

Transesophageal echocardiography (TEE) is a test that uses high-frequency sound waves to create images of the heart. It provides more detail that a standard echocardiogram. Vanderbilt researchers have created a software that creates an easy to follow, step-by-step procedure for a transesophageal echocardiography exam.

Vanderbilt scientists have developed an automated inflatable abdominal binder that can detect when a patient moves from a prone or sitting positon to a standing position and automatically apply a sustained servo-controlled compression pressure in order to counter the effects of OH. The binder is as effective as conventional drug therapy in controlling OH, without subjecting patients to potentially harmful side effects and interactions with other medications.

This research targets eNOS.